Skip to main content

Laurel Wealth Advisors LLC

SEC CIK
0001757128
Latest filing
Jul 17, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Laurel Wealth Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2021
Holdings of HRTX by Laurel Wealth Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−150−100.0%Sold outHolders
Q1 2022150$1.00K<0.1%00.0%UnchangedHolders
Q4 2021150$1.00K<0.1%00.0%UnchangedHolders
Q3 2021150$2.00K<0.1%00.0%UnchangedHolders
Q2 2021150$2.00K<0.1%+150NewHolders